Inission (INISS) Q1 & AGM 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 & AGM 2025 earnings summary
9 Jul, 2026Executive summary
Turnover for 2024 was SEK 2.15 billion, with a SEK 191 million drop in organic sales and a SEK 15 million drop in organic gross profit, mitigated by improved material share.
Q1 2025 sales decreased by 16.8% to SEK 484 million, with organic decline at 19.2%.
EBITDA for Q1 2025 was SEK 20 million (4.1% margin), down from 51.9 million (8.9% margin) year-over-year, impacted by lower volumes and one-time listing costs.
Order intake rose to SEK 606.8 million from SEK 377.1 million year-over-year.
Cost reduction programs are ongoing, with annualized costs about SEK 10 million lower year-over-year and full effect expected by Q4.
Financial highlights
2024 EBITDA margin: 5.8%; Q1 2025 EBITDA margin: 4.1%.
Q1 2025 cash flow was SEK 34 million, supported by improved working capital.
LTM EBITDA: SEK 93 million, margin 4.5%.
Net income per share was SEK 0.1 in Q1 2025, compared to SEK 1.7 last year.
Net debt increased to SEK 469.7 million; equity ratio at 38.9%.
Outlook and guidance
2025 targets: sales of SEK 2.2 billion, EBITDA/EBITA margin above 6%, equity ratio above 30%, dividend up to 30% of net profit.
Management maintains guidance but notes increased uncertainty due to global macro factors, especially U.S. tariffs.
Order book is 23% higher year-over-year, but volume growth is approached cautiously due to potential order delays.
Cost reduction programs are expected to show results in Q2 and beyond.
Management expects cost reductions to restore profitability even if volumes remain at Q1 levels.
Latest events from Inission
- Sales and margins rose strongly, with robust order intake and a positive outlook.INISS
Q2 2026 - Q1 2026 saw strong sales, margin growth, and robust order intake, signaling market recovery.INISS
Q1 2026 - 2025 revenue rose to SEK 2,206.2 million, with strong cash flow and a positive 2026 outlook.INISS
Q4 2025 - Sales fell 6.2%, but order intake, cash flow, and acquisitions signal H2 recovery.INISS
Q2 2025 - Revised targets and integration efforts position the company for renewed growth next year.INISS
ABGSC Investor Days - Sales and EBIT declined in Q3 2024, with cost cuts and revised targets amid market headwinds.INISS
Q3 2024 - Q2 sales up 1.4% to 570 MSEK, but organic growth and margins declined.INISS
Q2 2024 - Targeting 15% annual growth and 9% EBITDA margin, leveraging acquisitions and mega trends.INISS
CMD 2025 - Sales and margins fell, but order intake and cash flow rebounded; cost cuts and recovery expected.INISS
Q4 2024